Regeneron Pharmaceuticals and Sanofi have received FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in continual obstructive pulmonary illness.
in Business
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
